Summit Materials, Inc. (SUM) At $31.74 Forms Top; 0 Analysts Are Bullish Avinger, Inc. (AVGR) Last Week

Summit Materials, Inc. (SUM) formed multiple top with $34.60 target or 9.00% above today’s $31.74 share price. Summit Materials, Inc. (SUM) has $3.62B valuation. The stock increased 0.35% or $0.11 during the last trading session, reaching $31.74. About 968,767 shares traded. Summit Materials, Inc. (NYSE:SUM) has risen 29.53% since January 9, 2017 and is uptrending. It has outperformed by 12.83% the S&P500.

Among 3 analysts covering Avinger (NASDAQ:AVGR), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. Avinger had 3 analyst reports since December 29, 2015 according to SRatingsIntel. Dougherty & Company downgraded the stock to “Neutral” rating in Tuesday, December 29 report. The firm has “Hold” rating by Canaccord Genuity given on Tuesday, April 11. The rating was downgraded by Oppenheimer on Wednesday, April 12 to “Perform”. See Avinger, Inc. (NASDAQ:AVGR) latest ratings:

Avinger, Inc., a commercial-stage medical device company, designs, makes, and sells image-guided and catheter systems used by physicians to treat patients with peripheral arterial disease in the United States and Europe. The company has market cap of $7.06 million. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. It currently has negative earnings. The companyÂ’s lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients.

The stock increased 7.66% or $0.015 during the last trading session, reaching $0.215. About 2.26M shares traded or 71.85% up from the average. Avinger, Inc. (NASDAQ:AVGR) has declined 96.51% since January 9, 2017 and is downtrending. It has underperformed by 113.21% the S&P500.

Among 12 analysts covering Summit Materials (NYSE:SUM), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. Summit Materials had 32 analyst reports since August 17, 2015 according to SRatingsIntel. On Tuesday, October 10 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was downgraded by Goldman Sachs on Tuesday, October 11 to “Neutral”. RBC Capital Markets maintained it with “Buy” rating and $35.0 target in Wednesday, September 6 report. The stock has “Buy” rating by DA Davidson on Monday, August 17. The company was maintained on Wednesday, November 4 by RBC Capital Markets. The rating was upgraded by Bank of America to “Buy” on Thursday, October 8. RBC Capital Markets maintained Summit Materials, Inc. (NYSE:SUM) on Monday, June 19 with “Buy” rating. Stifel Nicolaus maintained the stock with “Buy” rating in Wednesday, September 6 report. The stock of Summit Materials, Inc. (NYSE:SUM) earned “Buy” rating by RBC Capital Markets on Monday, July 24. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, October 6.